Abstract:Yating Peng, 1– 3 Jiaxi Duan, 1– 3 Xin Li, 4 Yuqin Zeng, 1– 3 Zijing Zhou, 1– 3 Minghua Deng, 1– 3, 5 Ruoyun Ouyang, 1– 3 Yan Chen, 1– 3 Shan Cai, 1– 3 Ping Chen 1– 3 1 Department of Pulmonary and Critical Care Medicine, The Second Xiangya Hospital, Central South University, Changsha, Hunan, People's Republic of China; 2 Research Unit of Respiratory Disease, Central South University, Changsha, Hunan, People's Republic of China; 3 Hunan Centre for Evidence-Based Medicine, Changsha, Hunan, People's Republic of China; 4 Division of Occupational Lung Disease, Hunan Prevention and Treatment Institute for Occupational Diseases, Changsha, Hunan, People's Republic of China; 5 Department of Respiratory, PLA Rocket Force Characteristic Medical Center, Beijing, People's Republic of China Correspondence: Ping Chen Email Background: Pneumoconiosis has high prevalence of chronic obstructive pulmonary disease (COPD), respiratory morbidity, and mortality. Objective: The aim of the present study was to examine patient characteristics and adherence to inhaled therapy among pneumoconiosis with COPD in a real-world clinical setting. Methods: A cohort of pneumoconiosis patients with COPD prescript with at least one type of long-acting inhaled drug was followed for adherence for 2 years. Demographic and COPD-related characteristics were collected in baseline. Results: In baseline, after adjusting for age, dust exposure duration positively correlated with number of acute exacerbation (AE) frequency in the last year. There were close associations among COPD Assessment Tool (CAT) score, modified Medical Research Council Dyspnea Scale (mMRC) grade, number of AE, and pre-FEV 1 value. Of 296 participants originally recruited, 213 participants finished the 2-year follow-up for adherence. 122 (57.28%) were non-adherent to inhaled therapy. The most common reason for non-adherence was "relief of symptoms after short-term controller medication use" (53.28%). Patients who were non-adherent reported higher body mass index (BMI), less AE events in the last year, higher pre-FEV 1 value, higher post-FEV 1 value and low CAT, mMRC scores compared to adherent in baseline. High pre-FEV 1 value (OR = 1.04, CI = 1.018– 1.064) and low mMRC scores (OR = 0.406, CI = 0.214– 0.771) were risk factors found associated with non-adherence. Conclusion: A majority of pneumoconiosis patients complicated with COPD have suboptimal inhaled therapy adherence. Evidence-based, adherence-enhancing interventions should be targeted on less severe subjects. Keywords: adherence, inhaled therapy, pneumoconiosis, COPD COPD is a common, preventable, and treatable disease that is characterized by persistent respiratory symptoms and airflow limitation that is due to airway and/or alveolar abnormalities usually caused by significant exposure to noxious particles or gases. 1 Cigarette smoking is recognized as the most common and important cause of COPD. 2 Besides tobacco smoke, occupational exposures are important factors in COPD and other lung diseases. 2,3 Patients exposed to silicosis or coal have increased risk of COPD, our previous study 4 and other's study 5 have shown that the prevalence of COPD was up to 40% in pneumoconiosis in China. Notably, our group first reported that patients with COPD who suffered from occupational exposure developed more severe dyspnea than those exposed to tobacco alone. 6 Moreover, COPD patients exposed to occupational dust have distinct exposure pattern and different imaging and pathology features compared to those exposed to cigarette smoke. 2,7,8 The effect of dust on emphysema is small 7 but on opacity profusion and fibrosis 8 is prominent when compared to the effect of tobacco smoking. However, owing to the limited research on COPD patients exposed to occupational dust with or without cigarette smoke, relevant clinical characteristics and the prognosis is unclear. Recently, a large retrospective cohort study showed there is excess risk of death from COPD among workers with silicosis in Hong Kong, with smoking-adjusted standardized mortality ratio (SMR) of 2.03. 9 These drive us to pay attention to COPD patients with occupation dust exposure. The first-line drug treatment for COPD are inhaled bronchodilators or in combination with corticosteroids. There have been several studies which have explored adherence to inhaled therapy in COPD with varying results. 10 The levels of adherence among COPD patients are ranging from as low as -Abstract Truncated-

[Chinese expert consensus on treatment and management of chronic obstructive pulmonary disease combined with pneumoconiosis]

[Expert consensus on physician-pharmacist collaborative management of stable chronic obstructive pulmonary disease]

[The prevalence of common complications among pneumoconiosis patients: a systematic review and Meta-analysis]

Prevalence and Types of Comorbidities in Pneumoconiosis — China, 2018–2021

Adherence to Inhaled Therapy in Patients with COPD Associated to Pneumoconiosis

[Research on the therapeutic effects of drugs on patients with pneumoconiosis in China]

Interpretation of the Lancet Commission on Towards the Elimination of Chronic Obstructive Pulmonary Disease: New Definition and Recommendations for Clinical Management of Chronic Obstructive Pulmonary Disease

Guidelines of integrated Chinese and western medicine for diagnosis and treatment of chronic obstructive pulmonary disease (2022)

[Expert consensus of Chinese and Western medicine treatment on acute exacerbation of chronic obstructive pulmonary disease in China (2021)].

[Chinese expert consensus on diagnosis, treatment and prevention of pulmonary infection in patients with solid tumors (2024 edition)]

The Role of Long-Acting Muscarinic Antagonist/long-Acting Β Agonist Fixed-Dose Combination Treatment for Chronic Obstructive Pulmonary Disease in China: a Narrative Review

Clinical Outcomes and Risk Factor of Immune Checkpoint Inhibitors-Related Pneumonitis in Non-Small Cell Lung Cancer Patients with Chronic Obstructive Pulmonary Disease

Clinical efficacy of comprehensive therapy based on traditional Chinese medicine patterns on patients with pneumoconiosis: a pilot double-blind, randomized, and placebo-controlled study

Expert Consensus on Multi-Disciplinary Treatment, Whole-Course Pulmonary Rehabilitation Management in Patients with Lung Cancer and Chronic Obstructive Lung Disease.

Pneumoconiosis: current status and future prospects

COPD in China: the burden and importance of proper management.

Current status and preventive strategies of chronic obstructive pulmonary disease in China: a literature review

Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor.

Occupational survey-based evidence of health status and welfare problems of workers with pneumoconiosis in China

Patterns and Management of Chronic Obstructive Pulmonary Disease in Urban and Rural China: a Community-Based Survey of 25 000 Adults Across 10 Regions

[Present Status of Medical Treatment for Patients with Chronic Obstructive Pulmonary Disease Based Upon Different Severity Classifications].